Trial Profile
Bevacizumab+folfiri in untreated patients with advanced colorectal cancer. A phase II multicenter study of the Gruppo Oncologico dell'Italia Meridionale. (GOIM).
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Aug 2011
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Irinotecan; Levofolinic acid
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms GOIM
- 28 Aug 2011 New trial record